Stock listing
Seikagaku Corporation
Selected listing: SKUNF · OTC · USD · US
Seikagaku Corporation (OTC:SKUNF), Health Technology. Latest release Sep 24, 2026: Seikagaku Announces Revised Full-Year Consolidated and Non-Consolidated…
- Ticker
- OTC:SKUNF
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- OTC
- Currency
- USD
About Seikagaku Corporation
The company specializes in the development and commercialization of pharmaceuticals, particularly in the field of regenerative medicine and osteoarthritis treatment. Seikagaku is focused on advancing its innovative therapies to improve patient outcomes.
Latest news from Seikagaku Corporation
Seikagaku Announces Revised Full-Year Consolidated and Non-Consolidated Earnings Forecasts and Dividend Forecast
September 24, 2026
Seikagaku Announces Receipt of a Complete Response Letter Concerning the Biologics License Application in the U.S. for SI-6603
September 10, 2026
[Summary] Consolidated Financial Results for the Three Months Ended June 30, 2026 (Under Japanese GAAP)
August 5, 2026
Notice of Completion of Payment for Disposal of Treasury Shares as Restricted Stock Compensation
July 9, 2026
Notice Concerning Disposal of Treasury Shares as Restricted Stock Compensation
June 19, 2026
Research Seikagaku Corporation
Seikagaku Corporation company profile
View the public company page for Seikagaku Corporation on 6ix.
Seikagaku Corporation news
Read company news and market updates connected to Seikagaku Corporation.
Seikagaku Corporation investor events
Find investor webinars, events, and replay context for Seikagaku Corporation.